RecruitingNCT06527742

Body Composition, Frailty, and Function in Rehabilitation

Correlations of Body Composition Measures with Functional Outcomes and the Clinical Frailty Scale in Inpatient Rehabilitation: a Prospective Cohort Study


Sponsor

Changi General Hospital

Enrollment

345 participants

Start Date

Dec 9, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The investigators are investigating if body composition measures - in particular muscle mass, body fat, and something called the phase angle - are able to reliably predict functional outcomes for patients who are in an acute hospital for inpatient rehabilitation. The investigators also want to see if age and frailty affect these relationships. Patients undergoing inpatient rehabilitation in our hospital will be monitored through a variety of frailty-specific tools, including strength and speed. The investigators will use a device called a body composition monitor (BCM) to record their body composition measurements. These will then be compared against their usual rehabilitation outcomes. The investigators believe that there is a correlation between these measures and a patient's functional outcomes.


Eligibility

Min Age: 21 Years

Inclusion Criteria8

  • Transferred under the Rehabilitation Medicine service for post-acute rehabilitation
  • Rehabilitation diagnosis of:
  • Stroke with motor weakness (modified Rankin scale 1-5), or
  • Deconditioning (from sepsis, post-ICU admission, heart failure, falls, musculoskeletal conditions with or without pain, or other conditions), or
  • Pulmonary rehabilitation (with or with long-term oxygen therapy), or
  • Lower limb amputees (transtibial or transfemoral)
  • Medically stable
  • Able to understand English consent form or suitably-translated document, or have a family member/legally-authorised representative who is able to do so and willing to provide consent

Exclusion Criteria4

  • Pacemaker or implantable defibrillator in-situ
  • Medical devices or surgical implants that will interfere with BIA measurement per the manufacturer's guidelines
  • Abnormal fluid status (overloaded or depleted) at the point of screening
  • Cognitive or physical inability to tolerate sitting/lying still for 2mins (for BIA measurement)

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Changi General Hospital

Singapore, Singapore, Singapore

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06527742


Related Trials